Cargando…
Misrouting of glucagon and stathmin-2 towards lysosomal system of α-cells in glucagon hypersecretion of diabetes
Glucagon hypersecretion from the pancreatic α-cell is a characteristic sign of diabetes, which exacerbates fasting hyperglycemia. Thus, targeting glucagon secretion from α-cells may be a promising approach for combating hyperglucagonemia. We have recently identified stathmin-2 as an α-cell protein t...
Autores principales: | Asadi, Farzad, Dhanvantari, Savita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726656/ https://www.ncbi.nlm.nih.gov/pubmed/34923907 http://dx.doi.org/10.1080/19382014.2021.2011550 |
Ejemplares similares
-
Stathmin-2 Mediates Glucagon Secretion From Pancreatic α-Cells
por: Asadi, Farzad, et al.
Publicado: (2020) -
Plasticity in the Glucagon Interactome Reveals Novel Proteins That Regulate Glucagon Secretion in α-TC1-6 Cells
por: Asadi, Farzad, et al.
Publicado: (2019) -
Pathways of Glucagon Secretion and Trafficking in the Pancreatic Alpha Cell: Novel Pathways, Proteins, and Targets for Hyperglucagonemia
por: Asadi, Farzad, et al.
Publicado: (2021) -
In Situ Electrophysiological Examination of Pancreatic α Cells in the Streptozotocin-Induced Diabetes Model, Revealing the Cellular Basis of Glucagon Hypersecretion
por: Huang, Ya-Chi, et al.
Publicado: (2013) -
Reduced somatostatin signalling leads to hypersecretion of glucagon in mice fed a high-fat diet
por: Kellard, Joely A., et al.
Publicado: (2020)